Thus, the rationales for ameliorating allergic asthma and COPD by hesperetin are antiinflammation, immunoregulation, and bronchodilation resulted from PDE4 inhibition and are summarized in Figure 6. The gene discussed is PDE4A; the disease is chronic obstructive pulmonary disease.